FDAnews Drug Daily Bulletin

SOMAXON PHARMACEUTICALS CUTS IPO RANGE

Dec. 16, 2005
A A

Somaxon Pharmaceuticals Inc. on Wednesday said the estimated price range for its pending 5-million share initial public offering was cut to $10 to $12 a share. The estimated price had been $13 to $15 a share. The IPO would now be worth as much as $69 million, down from the $86.25 million originally estimated in October when the San Diego-based pharmaceutical company announced its plan to go public.

Seattle Post Intelligencer (http://seattlepi.nwsource.com/business/1310AP_Somaxon_Pharmaceuticals_IPO.html)